416
Views
23
CrossRef citations to date
0
Altmetric
Review

Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer

, , , , &
Pages 549-557 | Received 10 Nov 2016, Accepted 03 Feb 2017, Published online: 10 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ross E Staudt, Robert D Carlson & Adam E Snook. (2022) Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy. Cancer Biology & Therapy 23:1, pages 127-133.
Read now
Jessica Kopenhaver, Madison Crutcher, Scott A. Waldman & Adam E. Snook. (2021) The shifting paradigm of colorectal cancer treatment: a look into emerging cancer stem cell-directed therapeutics to lead the charge toward complete remission. Expert Opinion on Biological Therapy 21:10, pages 1335-1345.
Read now
Amanda N. Lisby, John C. Flickinger$suffix/text()$suffix/text(), Babar Bashir, Megan Weindorfer, Sanjna Shelukar, Madison Crutcher, Adam E. Snook & Scott A. Waldman. (2021) GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer. Expert Review of Precision Medicine and Drug Development 6:2, pages 117-129.
Read now
Jeffrey A. Rappaport & Scott A. Waldman. (2020) An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer. Expert Review of Clinical Pharmacology 13:10, pages 1125-1137.
Read now

Articles from other publishers (19)

Ravikant Sharma, Lalitha Suravarjhula, Madhuparna Banerjee, Gautam Kumar & Nitesh Kumar. (2023) Chimeric Antigen Receptor T-cell Therapy in Cancer: A Critical Review. Current Drug Research Reviews 15:3, pages 241-261.
Crossref
Pragya Rampuria, Lidia Mosyak, Adam R. Root, Kristine Svenson, Michael J. Agostino & Edward R. LaVallie. (2023) Molecular insights into recognition of GUCY2C by T-cell engaging bispecific antibody anti-GUCY2CxCD3. Scientific Reports 13:1.
Crossref
Jun Yuan, Jiarui Li, Ce Gao, Chun Jiang, Ze Xiang & Jian Wu. (2022) Immunotherapies catering to the unmet medical need of cold colorectal cancer. Frontiers in Immunology 13.
Crossref
Aneta Polewko-Klim, Sibo Zhu, Weicheng Wu, Yijing Xie, Ning Cai, Kexun Zhang, Zhen Zhu, Tao Qing, Ziyu Yuan, Kelin Xu, Tiejun Zhang, Ming Lu, Weimin Ye, Xingdong Chen, Chen Suo & Witold R. Rudnicki. (2022) Identification of Candidate Therapeutic Genes for More Precise Treatment of Esophageal Squamous Cell Carcinoma and Adenocarcinoma. Frontiers in Genetics 13.
Crossref
Cristina Jimenez-Luna, Encarnación González-Flores, Raul Ortiz, Luis J. Martínez-González, Alba Antúnez-Rodríguez, Manuela Expósito-Ruiz, Consolación Melguizo, Octavio Caba & Jose Prados. (2021) Circulating PTGS2, JAG1, GUCY2C and PGF mRNA in Peripheral Blood and Serum as Potential Biomarkers for Patients with Metastatic Colon Cancer. Journal of Clinical Medicine 10:11, pages 2248.
Crossref
Peng LüSonglin QiuYe PanFeng YuKeping Chen. (2021) Preclinical Chimeric Antibody Chimeric Antigen Receptor T Cell Progress in Digestive System Cancers. Cancer Biotherapy and Radiopharmaceuticals 36:4, pages 307-315.
Crossref
Azar Dokht Khosravi, Ali Teimoori & Sakineh Seyed-Mohammadi. (2021) Construction of a recombinant Lactobacillus casei expressing fliC gene fused with guanylyl cyclase C and dendritic cell-binding peptide using CRISPR–Cas9 system: a first step towards design of vaccine against colorectal cancer. Reviews in Medical Microbiology 32:2, pages 114-123.
Crossref
Ke-Tao Jin, Bo Chen, Yu-Yao Liu, H uan-Rong Lan & Jie-Ping Yan. (2021) Monoclonal antibodies and chimeric antigen receptor (CAR) T cells in the treatment of colorectal cancer. Cancer Cell International 21:1.
Crossref
John C FlickingerJrJr, Jeffrey A Rappaport, Joshua R Barton, Trevor R Baybutt, Amanda M Pattison, Adam E Snook & Scott A Waldman. (2021) Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies. Biomarkers in Medicine.
Crossref
Yasmin Kamal, Stephanie L Schmit, Hildreth Robert Frost & Christopher I Amos. (2020) The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy. Immunotherapy 12:14, pages 1083-1100.
Crossref
Emilie Picard, Chris P. Verschoor, Grace W. Ma & Graham Pawelec. (2020) Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer. Frontiers in Immunology 11.
Crossref
Katia Cappelli, Rodolfo Gialletti, Beniamino Tesei, Gabrio Bassotti, Katia Fettucciari, Stefano Capomaccio, Laura Bonfili, Massimiliano Cuccioloni, Anna Maria Eleuteri, Andrea Spaterna & Fulvio Laus. (2019) Guanylin, Uroguanylin and Guanylate Cyclase-C Are Expressed in the Gastrointestinal Tract of Horses. Frontiers in Physiology 10.
Crossref
Mrinalini C. Rao. 2011. Comprehensive Physiology. Comprehensive Physiology 947 1023 .
Stella Nikolaou, Shengyang Qiu, Francesca Fiorentino, Shahnawaz Rasheed, Paris Tekkis & Christos Kontovounisios. (2018) The prognostic and therapeutic role of hormones in colorectal cancer: a review. Molecular Biology Reports 46:1, pages 1477-1486.
Crossref
Shan Xie, Jia Huang, Qin Qiao, Wenjuan Zang, Shanjuan Hong, Haidong Tan, Chen Dong, Zhiying Yang & Ling Ni. (2018) Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors. Cancer Immunology, Immunotherapy 67:11, pages 1685-1694.
Crossref
Angelika Fretzen. (2018) Peptide therapeutics for the treatment of gastrointestinal disorders. Bioorganic & Medicinal Chemistry 26:10, pages 2863-2872.
Crossref
Michael S. Magee, Tara S. Abraham, Trevor R. Baybutt, John C. FlickingerJrJr, Natalie A. Ridge, Glen P. Marszalowicz, Priyanka Prajapati, Adam R. Hersperger, Scott A. Waldman & Adam E. Snook. (2018) Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases. Cancer Immunology Research 6:5, pages 509-516.
Crossref
Andreas Friebe, Peter Sandner & Achim Schmidtko. (2017) Meeting report of the 8th International Conference on cGMP “cGMP: generators, effectors, and therapeutic implications” at Bamberg, Germany, from June 23 to 25, 2017. Naunyn-Schmiedeberg's Archives of Pharmacology 390:12, pages 1177-1188.
Crossref
Reza Nedaeinia, Amir Avan, Mehdi Ahmadian, Sasan Nedaee Nia, Maryam Ranjbar, Mohammadreza Sharifi, Mohammad Goli, Ahmad Piroozmand, Esmail Nourmohammadi, Mostafa Manian, Gordon A. Ferns, Majid Ghayour‐Mobarhan & Rasoul Salehi. (2017) Current Status and Perspectives Regarding LNA‐Anti‐miR Oligonucleotides and microRNA miR‐21 Inhibitors as a Potential Therapeutic Option in Treatment of Colorectal Cancer. Journal of Cellular Biochemistry 118:12, pages 4129-4140.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.